In this study, we used data from over 500 HNSCC patients from the Cancer Genome Atlas (TCGA) to compare the expression levels of mRNA for NSD1, NSD2, and NSD3 between HPV+ HNSCC, HPV- HNSCC, or normal control tissues. This evidence concerns the gene NSD3 and head and neck squamous cell carcinoma.